Antineoplaston Therapy in Treating Patients With Stomach Cancer
Status:
Terminated
Trial end date:
1998-08-24
Target enrollment:
Participant gender:
Summary
Current therapies for Stomach Cancer provide very limited benefit to the patient. The
anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the
treatment of Stomach Cancer.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on patients with Stomach Cancer.